Optio Biopharma Solutions attends the 23rd Annual Huntington’s Study Group Meeting and 10th Annual Clinical Research Symposium in Nashville, TN.

November 2016 – Optio Biopharma Solutions interviews neurology thought leaders specializing in movement disorders for a international competitive intelligence (CI) project aimed at understanding industry best practices for support programs. This CI project was especially large and involved both desk and primary research involving feedback from hundreds of respondents working in several large prevalence disease therapeutic areas in the US, Europe, and Brazil. Attending this meeting was a cost-effective opportunity to engage with thought leaders on the neurological disease portion of the project.